FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Craig Mullen

Research Profile

Living Beings

Procedures

Chemicals & Drugs

Disorders

Anatomy

Devices

Gene Transfer Techniques

Physiology

Co-author Network

Publications

TOP 3
Craig A Mullen
"Good enough" medicine: noninferiority clinical trials and the management of fever and neutropenia.
Laurie A Milner; Craig A Mullen; Talia Sasson; Michael W Becker; Steven H Bernstein; Lauren Bruckner; Jonathan W Friedberg; George A Holland; J J Ifthikharuddin; Jane L Liesveld; Edward J Mathes; Heather L Menchel; Gordon L Phillips
Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease.
Johan Jansson; Igor I Kuzin; Andrew Campbell; Yu-Chiao Hsu; Craig A Mullen
Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Craig Mullen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Craig A Mullen
"Good enough" medicine: noninferiority clinical trials and the management of fever and neutropenia.
Pediatric blood & cancer 2012;59(3):415-6.
2011: Laurie A Milner; Craig A Mullen; Talia Sasson; Michael W Becker; Steven H Bernstein; Lauren Bruckner; Jonathan W Friedberg; George A Holland; J J Ifthikharuddin; Jane L Liesveld; Edward J Mathes; Heather L Menchel; Gordon L Phillips
Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease.
American journal of hematology 2011;86(8):712-4.
2011: Johan Jansson; Igor I Kuzin; Andrew Campbell; Yu-Chiao Hsu; Craig A Mullen
Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects.
Leukemia research 2011;35(6):800-7.
2011: Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(4):e56-93.
2011: Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(4):427-31.
2011: Craig A Mullen; Andrew Campbell; Olena Tkachenko; Johan Jansson; Yu-Chiao Hsu
Evidence of B cell immune responses to acute lymphoblastic leukemia in murine allogeneic hematopoietic stem cell transplantation recipients treated with donor lymphocyte infusion and/or vaccination.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(2):226-38.
2010: Jessica C Shand; Johan Jansson; Yu-Chiao Hsu; Andrew Campbell; Craig A Mullen
Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant.
Cancer immunology, immunotherapy : CII 2010;59(11):1633-44.
2009: Shalu Narang; Jason Roy; Timothy P Stevens; Meggan Butler-O'Hara; Craig A Mullen; Carl T D'Angio
Risk factors for umbilical venous catheter-associated thrombosis in very low birth weight infants.
Pediatric blood & cancer 2009;52(1):75-9.
2008: Faith Young; Andrew Campbell; Kris Lambert Emo; Johan Jansson; Pin-Yi Wang; Craig T Jordan; Craig A Mullen
High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(6):622-30.
2007: Gerardo Quezada; Theresa Sunderland; Ka Wah Chan; Kenneth Rolston; Craig A Mullen
Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
Pediatric blood & cancer 2007;48(3):273-7.
2007: Amanda Martinelli Natzke; Joanne L Shaw; Morgan McKeller; Kris Lambert Emo; Craig A Mullen
Hematopoietic stem cell recipients do not develop post-transplantation immune tolerance to antigens present on minimal residual disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(1):34-45.
2006: Demetrios Petropoulos; Laura L Worth; Craig A Mullen; S Lockhart; Mary Choroszy; Ka Wah Chan
Interferon-alpha after autologous stem cell transplantation in pediatric patients with advanced Hodgkin's lymphoma.
Bone marrow transplantation 2006;38(5):345-9.
2006: Demetrios Petropoulos; Laura L Worth; Craig A Mullen; R Madden; A Mahajan; Mary Choroszy; Chul Ha; R C Champlin; Ka Wah Chan
Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies.
Bone marrow transplantation 2006;37(5):463-7.
2005: Mallika Kamana; Carmen P Escalante; Craig A Mullen; Susan Frisbee-Hume; Kenneth V I Rolston
Bacterial infections in low-risk, febrile neutropenic patients.
Cancer 2005;104(2):422-6.
2005: Shailendra Mundhada; Joanne Shaw; Shahram Mori; Cherylyn A Savary; Craig A Mullen
Cellular tumor vaccines administered after T cell-depleted allogeneic bone marrow transplantation induce effective anti-tumor immune responses.
Leukemia & lymphoma 2005;46(4):571-80.
2005: S Mori; U Kocak; Joanne L Shaw; Craig A Mullen
Augmentation of post transplant immunity: antigen encounter at the time of hematopoietic stem cell transplantation enhances antigen-specific donor T-cell responses in the post transplant repertoire.
Bone marrow transplantation 2005;35(8):793-801.
2004: Hai Tran; Demetrios Petropoulos; Laura L Worth; Craig A Mullen; Timothy Madden; Borje Andersson; Mary Choroszy; John Nguyen; Susannah K Webb; Ka Wah Chan
Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(11):805-12.
2003: Craig A Mullen
Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
The Pediatric infectious disease journal 2003;22(12):1138-42.
2003: Nancy Gordon; Craig A Mullen; Hai Tran; Laura L Worth; David Gomez-Almaguer; Ka Wah Chan
Fludarabine and once-daily intravenous busulfan for allogeneic bone marrow transplantation for Chediak-Higashi syndrome.
Journal of pediatric hematology/oncology 2003;25(10):824-6.
2003: Shahram Mori; H El-Baki; Craig A Mullen
Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;31(10):865-75.
2003: Craig A Mullen; H Abd El-Baki; H Samir; Jeffrey J Tarrand; Kenneth V I Rolston
Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(5):321-5.
2002: Laura L Worth; Craig A Mullen; Mary Choroszy; Susannah Koontz; KaWah Chan
Treatment of leukemia relapse with recombinant granulocyte-macrophage colony stimulating factor (rhGM-CSF) following unrelated umbilical cord blood transplant: Induction of graft-vs.-leukemia.
Pediatric transplantation 2002;6(5):439-42.
2002: David Farquhar; Bih Fang Pan; Mamoru Sakurai; Ajit Ghosh; Craig A Mullen; J Arly Nelson
Suicide gene therapy using E. coli beta-galactosidase.
Cancer chemotherapy and pharmacology 2002;50(1):65-70.
2002: Ka Wah Chan; Craig A Mullen; Laura L Worth; Mary Choroszy; S Koontz; Hai Tran; John M Slopis
Lorazepam for seizure prophylaxis during high-dose busulfan administration.
Bone marrow transplantation 2002;29(12):963-5.
2002: Craig A Mullen
Influence of tumor vaccines on graft versus tumor activity and graft versus host disease in allogeneic bone marrow transplantation.
Leukemia & lymphoma 2002;43(3):503-10.
2002: Jun Wang; Joanne L Shaw; Craig A Mullen
Down-regulation of antihost alloreactivity after bone marrow transplant permits relapse of hematological malignancy.
Cancer research 2002;62(1):208-12.
2002: Ulker Koçak; Kenneth V I Rolston; Craig A Mullen
Fever and neutropenia in children with solid tumors is similar in severity and outcome to that in children with leukemia.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2002;10(1):58-64.
2001: E P Baorto; V M Aquino; Craig A Mullen; G R Buchanan; M R DeBaun
Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia.
Cancer 2001;92(4):909-13.
2001: L A Everse; LD Anderson; N van Rooijen; Craig A Mullen
Bone marrow transplant conditioning intensified with liposomal clodronate to eliminate residual host antigen presenting cells fails to ameliorate GVHD and increases PERI-BMT mortality.
Transplantation 2001;71(5):611-8.
2001: Craig A Mullen
Which children with fever and neutropenia can be safely treated as outpatients?
British journal of haematology 2001;112(4):832-7.
2000: Craig A Mullen; K W Chan
Ethical considerations in allogeneic hematopoietic cell transplantation for children with slowly fatal conditions.
Bone marrow transplantation 2000;26(9):1030-1.
2000: LD Anderson; Shahram Mori; S Mann; Cherylyn A Savary; Craig A Mullen
Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
Cancer research 2000;60(20):5797-802.
2000: Craig A Mullen; J N Thompson; L A Richard; Ka Wah Chan
Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia.
Bone marrow transplantation 2000;25(10):1093-7.
2000: Fabio Candotti; Riad Agbaria; Craig A Mullen; RL Touraine; J Balzarini; David G Johns; R. Michael Blaese
Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer.
Cancer gene therapy 2000;7(4):574-80.
2000: LD Anderson; Cherylyn A Savary; Craig A Mullen
Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease.
Blood 2000;95(7):2426-33.
2000: Craig A Mullen; J Nair; S Sandesh; Ka Wah Chan
Fever and neutropenia in pediatric hematopoietic stem cell transplant patients.
Bone marrow transplantation 2000;25(1):59-65.
1999: Laura L Worth; Hai Tran; Demetrios Petropoulos; SJ Culbert; Craig A Mullen; W Roberts; Donna Przepiorka; K Chan
Hematopoietic stem cell transplantation for childhood myeloid malignancies after high-dose thiotepa, busulfan and cyclophosphamide.
Bone marrow transplantation 1999;24(9):947-52.
1999: Craig A Mullen; Demetrios Petropoulos; W Mark Roberts; Michael Rytting; Theodore F Zipf; Ka Wah Chan; SJ Culbert; Martha G Danielson; Sima Jeha; John Frank Kuttesch; Kenneth V I Rolston
Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Cancer 1999;86(1):126-34.
1999: Donna Przepiorka; Demetrios Petropoulos; Craig A Mullen; Martha G Danielson; V Mattewada; Ka Wah Chan
Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation.
Bone marrow transplantation 1999;23(12):1291-5.
1999: Shigeki Kuriyama; Masaji Kikukawa; K Masui; H Okuda; Toshiya Nakatani; T Sakamoto; Hitoshi Yoshiji; Hiroshi Fukui; K Ikenaka; Craig A Mullen; Tadasu Tsujii
Cytosine deaminase/5-fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice.
International journal of cancer. Journal international du cancer 1999;81(4):592-7.
1999: Craig A Mullen; Demetrios Petropoulos; W Mark Roberts; Michael Rytting; Theodore F Zipf; Ka Wah Chan; SJ Culbert; Martha G Danielson; Sima Jeha; John Frank Kuttesch; Kenneth V I Rolston
Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer.
Journal of pediatric hematology/oncology 1999;21(3):212-8.
1999: LD Anderson; Demetrios Petropoulos; L A Everse; Craig A Mullen
Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine.
Cancer research 1999;59(7):1525-30.
1999: Cynthia Dunbar; L Chang; Craig A Mullen; W J Ramsey; Charles Carter; D Kohn; Robertson Parkman; Carl Lenarsky; Kenneth I Weinberg; Diane Wara; KW Culver; W F Anderson; Susan F Leitman; Thomas A Fleisher; HARVEY KLEIN; G Shearer; Mario Clerici; GJ McGarrity; John Bastian; Michael S Hershfield
Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene.
Human gene therapy 1999;10(3):477-88.
1999: JA Ragheb; L Couture; Craig A Mullen; A Ridgway; Richard A Morgan
Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev.
Human gene therapy 1999;10(1):103-12.
1998: Craig A Mullen; L Anderson; K Woods; M Nishino; Demetrios Petropoulos
Ganciclovir chemoablation of herpes thymidine kinase suicide gene-modified tumors produces tumor necrosis and induces systemic immune responses.
Human gene therapy 1998;9(14):2019-30.
1998: Shigeki Kuriyama; K Masui; T Sakamoto; Toshiya Nakatani; Masaji Kikukawa; Hirohisa Tsujinoue; Akira Mitoro; Masaharu Yamazaki; Hitoshi Yoshiji; Hiroshi Fukui; K Ikenaka; Craig A Mullen; Tadasu Tsujii
Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.
Anticancer research 1998;18(5A):3399-406.
1998: Craig A Mullen; Demetrios Petropoulos; Michael Rytting; Sima Jeha; Theodore F Zipf; W Mark Roberts; Kenneth V I Rolston
Acute reversible arthropathy in a pediatric patient with cancer treated with a short course of ciprofloxacin for febrile neutropenia.
Journal of pediatric hematology/oncology 1998;20(5):516-7.
1998: Y Su; M M Yamashita; Samantha E Greasley; Craig A Mullen; JH Shim; Patricia Jennings; Stephen J Benkovic; Ian A Wilson
A pH-dependent stabilization of an active site loop observed from low and high pH crystal structures of mutant monomeric glycinamide ribonucleotide transformylase at 1.8 to 1.9 A.
Journal of molecular biology 1998;281(3):485-99.
1998: K W Chan; Craig A Mullen; M Korbling
Allogeneic peripheral blood stem cell transplantation for active hemophagocytic lymphohistiocytosis.
Bone marrow transplantation 1998;22(3):301-2.
1998: Robert E Walker; C S Carter; Linda Muul; Ven Natarajan; Betsey Herpin; Susan F Leitman; HARVEY KLEIN; Craig A Mullen; Julia A Metcalf; Michael Baseler; Judith Falloon; Richard Davey; Joseph A Kovacs; Michael A Polis; Henry Masur; R. Michael Blaese; H Clifford Lane
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults.
Nature medicine 1998;4(7):852-6.
1998: Craig A Mullen; Patricia Jennings
A single mutation disrupts the pH-dependent dimerization of glycinamide ribonucleotide transformylase.
Journal of molecular biology 1998;276(4):819-27.
1998: Craig A Mullen
Review: analogies between trophoblastic and malignant cells.
American journal of reproductive immunology (New York, N.Y. : 1989) 1998;39(1):41-9.
1997: A Kumar; Y H Kang; K Gowda; Craig A Mullen; D M Gordon; S Kumar; Stephen L Hoffman
Autologous lymphoblastoid cell lines stably transfected with Plasmodium falciparum circumsporozoite protein as targets in cytotoxic T-lymphocyte assays.
Immunology letters 1997;55(3):183-7.
1997: H Ishii-Morita; Riad Agbaria; Craig A Mullen; H Hirano; D A Koeplin; Z Ram; Edward H Oldfield; David G Johns; R. Michael Blaese
Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment.
Gene therapy 1997;4(3):244-51.
1996: Craig A Mullen; Patricia Jennings
Glycinamide ribonucleotide transformylase undergoes pH-dependent dimerization.
Journal of molecular biology 1996;262(5):746-55.
1996: Craig A Mullen
Strategies for success: preparing for the certification examination.
Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses / American Society of PeriAnesthesia Nurses 1996;11(5):324-9.
1996: Craig A Mullen; K Snitzer; KW Culver; Richard A Morgan; W F Anderson; R. Michael Blaese
Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: long-term expression in vivo of genes introduced with a retroviral vector.
Human gene therapy 1996;7(9):1123-9.
1996: Craig A Mullen; Demetrios Petropoulos; R M Lowe
Treatment of microscopic pulmonary metastases with recombinant autologous tumor vaccine expressing interleukin 6 and Escherichia coli cytosine deaminase suicide genes.
Cancer research 1996;56(6):1361-6.
1996: Mark Khil; Jae Ho Kim; Craig A Mullen; S H Kim; Svend O Freytag
Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(1):53-7.
1996: Craig A Mullen; R. Michael Blaese
Gene therapy of cancer.
Cancer chemotherapy and biological response modifiers 1996;16():285-94.
1995: R. Michael Blaese; KW Culver; A D Miller; Charles S Carter; Thomas A Fleisher; M Clerici; G Shearer; L Chang; Y Chiang; P Tolstoshev; J J Greenblatt; STEVEN ROSENBERG; HARVEY KLEIN; M Berger; Craig A Mullen; W J Ramsey; L Muul; Richard A Morgan; W French Anderson
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.
Science (New York, N.Y.) 1995;270(5235):475-80.
1995: W J Ramsey; Craig A Mullen; R. Michael Blaese
Retrovirus mediated gene transfer as therapy for adenosine deaminase (ADA) deficiency.
Leukemia 1995;9 Suppl 1():S70.
1995: M Consalvo; Craig A Mullen; Andrea Modesti; Piero Musiani; Attilio Allione; Federica Cavallo; Mirella Giovarelli; Guido Forni
5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(10):5302-12.
1994: Kathleen E Sullivan; Craig A Mullen; R. Michael Blaese; Jerry A Winkelstein
A multiinstitutional survey of the Wiskott-Aldrich syndrome.
The Journal of pediatrics 1994;125(6 Pt 1):876-85.
1994: Craig A Mullen
Metabolic suicide genes in gene therapy.
Pharmacology & therapeutics 1994;63(2):199-207.
1994: L A Couture; Craig A Mullen; Richard A Morgan
Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
Human gene therapy 1994;5(6):667-77.
1994: Riad Agbaria; Craig A Mullen; N R Hartman; D A Cooney; Z Hao; R. Michael Blaese; David G Johns
Effects of IMP dehydrogenase inhibitors on the phosphorylation of ganciclovir in MOLT-4 cells before and after herpes simplex virus thymidine kinase gene transduction.
Molecular pharmacology 1994;45(4):777-82.
1994: Craig A Mullen; M M Coale; R Lowe; R. Michael Blaese
Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.
Cancer research 1994;54(6):1503-6.
1994: Craig A Mullen; R. Michael Blaese
Gene therapy of cancer.
Cancer chemotherapy and biological response modifiers 1994;15():176-89.
1994: R. Michael Blaese; H Ishii-Morita; Craig A Mullen; J Ramsey; Zvi Ram; E Oldfield; KW Culver
In situ delivery of suicide genes for cancer treatment.
European journal of cancer (Oxford, England : 1990) 1994;30A(8):1190-3.
1993: Craig A Mullen; K D Anderson; R. Michael Blaese
Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases.
Blood 1993;82(10):2961-6.
1993: R. Michael Blaese; Craig A Mullen; W J Ramsey
Strategies for gene therapy.
Pathologie-biologie 1993;41(8):672-6.
1993: Robert E Walker; R. Michael Blaese; C S Carter; L Chang; HARVEY KLEIN; H Clifford Lane; S F Leitman; Craig A Mullen; M Larson
A study of the safety and survival of the adoptive transfer of genetically marked syngeneic lymphocytes in HIV-infected identical twins.
Human gene therapy 1993;4(5):659-80.
1993: R. Michael Blaese; KW Culver; L Chang; W French Anderson; Craig A Mullen; A Nienhuis; Charles Carter; Cynthia Dunbar; Susan F Leitman; M Berger
Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992.
Human gene therapy 1993;4(4):521-7.
1992: Craig A Mullen; M M Coale; A T Levy; William Stetler-Stevenson; Lance A Liotta; S Brandt; R. Michael Blaese
Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential.
Cancer research 1992;52(21):6020-4.
1992: Craig A Mullen; M Kilstrup; R. Michael Blaese
Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(1):33-7.
1990: Craig A Mullen; George R Buchanan
Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(12):1998-2004.
1989: Craig A Mullen; D A Rowley; Hans Schreiber
Highly immunogenic regressor tumor cells can prevent development of postsurgical tumor immunity.
Cellular immunology 1989;119(1):101-13.
1986: L V Abruzzo; Craig A Mullen; D A Rowley
Immunoregulation by natural killer cells.
Cellular immunology 1986;98(2):266-78.
1985: Craig A Mullen; J L Urban; C Van Waes; D A Rowley; Hans Schreiber
Multiple cancers. Tumor burden permits the outgrowth of other cancers.
The Journal of experimental medicine 1985;162(5):1665-82.
1985: Craig A Mullen; H Schreiber
Tumor growth and evasion of immune destruction: UV-induced tumors as a model.
Survey of immunologic research 1985;4(4):264-70.